ArticleJNCI cancer spectrum2026

Heterogeneous treatment effect of immune checkpoint inhibitors by pretreatment prognosis in randomized controlled trials.

Lee X Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.